Quanterix (NASDAQ:QTRX) Upgraded at The Goldman Sachs Group

The Goldman Sachs Group upgraded shares of Quanterix (NASDAQ:QTRX – Get Rating) from a neutral rating to a buy rating in a research report released on Tuesday, The Fly reports. They currently have $27.00 price target on the stock, up from their previous price target of $13.00.

Quanterix Price Performance

Shares of QTRX opened at $20.76 on Tuesday. The firm has a market cap of $776.63 million, a P/E ratio of -9.11 and a beta of 1.34. The stock has a 50 day simple moving average of $14.11 and a two-hundred day simple moving average of $13.31. Quanterix has a 1 year low of $6.31 and a 1 year high of $23.44.

Quanterix (NASDAQ:QTRX – Get Rating) last issued its earnings results on Monday, March 6th. The company reported ($0.50) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.53) by $0.03. The business had revenue of $25.82 million during the quarter, compared to analyst estimates of $26.16 million. Quanterix had a negative return on equity of 17.22% and a negative net margin of 81.08%. During the same quarter in the prior year, the firm earned ($0.55) earnings per share. On average, equities analysts anticipate that Quanterix will post -1.19 earnings per share for the current year.

Institutional Trading of Quanterix

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Ameriprise Financial Inc. boosted its stake in Quanterix by 20.2% in the first quarter. Ameriprise Financial Inc. now owns 1,026,041 shares of the company’s stock worth $11,563,000 after buying an additional 172,719 shares in the last quarter. Perceptive Advisors LLC purchased a new stake in Quanterix in the first quarter worth approximately $1,465,000. Jane Street Group LLC purchased a new stake in Quanterix in the first quarter worth approximately $157,000. State Street Corp boosted its stake in shares of Quanterix by 2.3% during the first quarter. State Street Corp now owns 693,739 shares of the company’s stock valued at $7,818,000 after purchasing an additional 15,791 shares during the period. Finally, Geode Capital Management LLC boosted its stake in shares of Quanterix by 4.7% during the first quarter. Geode Capital Management LLC now owns 670,322 shares of the company’s stock valued at $7,555,000 after purchasing an additional 30,163 shares during the period. Hedge funds and other institutional investors own 80.60% of the company’s stock.

About Quanterix

(Get Rating)

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development.